The dramatic response to colchicine was remarkable. Within 48 hours a re-accumulated pericardial effusion causing right ventricular strain had disappeared as had clinically apparent ascites. Most autoimmune, infective or malignant aetiologies would not be expected to respond in such a way and a yet undiscovered autoinflammatory syndrome remains a tantalising possibility. Keylearningpoints:Mainlearningpointssofar:Maintainawidedifferential in patients presenting with polyserositis, especially when there is a poor response to typical management approaches. Consider autoinflammatory disease and take a detailed past medical and family history. Colchicine is cheap and generally well tolerated at lower doses. Colchicine isfirst line therapyforrecurrent pericarditis. Learning points from the conference: What's her risk of developing secondary amyloid or other secondary sequelae? How long will she need treatment for and how/ when you would you wean the colchicine? Is her partial Greek genetic heritage relevant? How common are wild type genetic polymorphisms occurring in autoinflammatory conditions? How frequently is colitis a feature of autoinflammatory diseases? If she becomes unwell again what would your second line therapybe? Conflicts of interest: The authors have declared no conflicts of interest.
A CHALLENGING DIAGNOSIS OF ADULT-ONSET STILL'S DISEASE IN THE SETTING OF RAISED ANTI-STREPTOLYSIN O TITRES
Mareen Joy 1 , Liora Wittner 1 , and Spencer Ellis 1 1 Rheumatology, East and North Hertfordshire NHS Trust, Stevenage, United Kingdom Introduction: We describe a case of a 40-year-old male with recurrent episodes of fever, polyarthralgia, myalgia and pharyngitis. Investigations revealed intermittent transaminitis and high serum ferritin, but also positive streptococcal serology, despite negative microbiology. This case illustrates the challenges faced when diagnosing adult-onset Still's disease (AOSD) and distinguishing between alternative diagnoses, such as post streptococcal reactive arthritis (PSRA). It is important to differentiate between these conditions as theyhave different organ involvement,monitoringrequirements,treatments andprognoses. Thiscasehasprompted a review of studies where the frequencies of clinical and serological features are noted in these two conditions. Case description: A 40-year-old male was referred to acute medicine with3monthsofheadache, fatigue, polyarthralgia, myalgia,nightsweats, lymphadenopathy and otalgia. He reported a severe pharyngitis at symptom onset, 12 weeks earlier, for which he was given 20 days of phenoxymethylpenicillin by his GP. His sore throat improved, but his other symptoms persisted. His GP then suspected sinusitis, so prescribed doxycycline. He had no significant past medical history other than a tonsillectomyin his 20sand had been onnoregularmedication. On admission, he reported fever, headache, sweats, myalgia and arthralgia ofthe elbows andwrists.Hehad nomeningismanddenied anyrashes, nasal discharge, joint swelling, neurological symptoms, weight loss or symptoms to suggest underlying malignancy. An ENT specialist felt sinusitis to be unlikely. On examination, the initial positive findings included tenderness of the right mastoid process, low grade cervical lymphadenopathy, tender wrists, erythematous pharynx and myalgia of the thighs. There was no rash, clinical synovitis, ororganomegaly. Investigations included: Throat cultures: negative; Urine dip: trace blood; Anti-Streptolysin O Titres (ASOT): 1600 units/ml; Anti-DNAse B titres: 800; WCC: 16, neutrophils: 73%; ESR: 62; CRP: 120; Ferritin: 1322 (5x upper limit of normal); Transaminitis: ALT: 234, AST: 123; LDH: 428; CK: 47; ANCA, ANA, rheumatoid factor, anti-CCP, CMV, EBV, hepatitis A, B & C, HIV: negative; Echocardiogram: normal; CT head, chest, abdomen, pelvis: normal Our patient was referred to rheumatology and treatment for presumed AOSD was commenced with 30mg prednisolone (weaning dose) and methotrexate. His arthralgia and systemic symptoms vastly improved within one month. At that stage his ASOT was noted to have risen further to 3200 units/ml. He has stopped all medications after one year of treatment. Two months after cessation of methotrexate he remains asymptomatic, with marginally elevated ferritin but otherwise normal routine bloods. Discussion: This case illustrates the difficulties involved in establishing an AOSD diagnosis. Despite meeting the Yamaguchi criteria, serositis, maculopapular rash and documented quotidian fever were absent. ASOT levels were elevated and rose after presentation, whilst pharyngitis had been evident at symptom onset, which could imply an alternative differential of PSRA.
Identification of AOSD is important as it necessitates monitoring forcardiopulmonary manifestations and rarely macrophage activation syndrome. In AOSD, IL6-IL1 blockade is used for recalcitrant disease. For PSRA, it is important to ensure there are no features of acute rheumatic fever, renal disease,or cardiac disease. PSRA was less likely due to liver and ferritin abnormalities, which persisted long after CRP normalisation, persistent lymphadenopathy and negativethroat swabs. Therise in ASOT was considered afalse positive. The table compares clinicaland serological features forthe conditions. Key learning points: There can be diagnostic uncertainty regarding the diagnosis of AOSD, particularly as other conditions may share clinical features, such as recurrent pharyngitis with polyarthralgia/arthritis. PSRA is an important condition to keep in mind when investigating and managing these patients. Both conditions can present with polyarthralgia, but the chronic arthritis of AOSD can progress to destructive arthropathy. The rashes in both conditions generally differ, helping to distinguish between the two. Persistent pyrexia and pharyngitis would be rare in PSRA unless the patient is having recurrent streptococcal infections. Therefore,it is important toperform ENT examinationwith bacterial throat swabs and forthe patient to keep afever diary. Similarly, cervical lymphadenopathy should only be present during the acute phase of the streptococcal infection rather than persistently, as in the case of AOSD. Hepatosplenomegaly and haematological manifestations are more strongly associated with AOSD, so if these features are present there is greater diagnostic certainty, as long as infection and malignancy can be ruled out. ASOT can be falsely positive due to cross reactivity with myeloma, liver disease, hypergammaglobulinaemia, and autoimmune disease associated with increased rheumatoid factor. ASOT levels peak at 3 weeks and decrease at 8 weeks, and only decreases to pre-infectious levels at 8 months. Anti-DNAse B peaks at 6-8 weeks, decreases at 12 weeks and returns to pre-infectious levels at 12 months. Therefore, the timeline of possible streptococcal infection is important, as even if the infection was months prior, ASOT may be elevated. Repeating both titres is useful, as a disproportionate rise in anti-DNASe B compared with ASOT suggests an acute infection. ASOT may remain elevated for many months in the pharyngeal carrierstate. It wouldbeinterestingtoclarifythe experience of othercentresinthe identificationof raised ASOT in AOSD.
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